<?xml version="1.0" encoding="UTF-8"?>
<p>
 <xref rid="tab6" ref-type="table">Table 6</xref> shows 
 <italic>IGESE</italic>'s 
 <italic>in vitro</italic> ferric reducing activity power of 25 
 <italic>μ</italic>g/ml, 50 
 <italic>μ</italic>g/ml, 75 
 <italic>μ</italic>g/ml, and 100 
 <italic>μ</italic>g/ml in comparison with those of corresponding doses of the standard antioxidant drug. Again, 
 <italic>IGESE</italic>'s FRAP activities were significantly (
 <italic>p</italic> &lt; 0.05, 
 <italic>p</italic> &lt; 0.001, 
 <italic>p</italic> &lt; 0.0001) dose dependent and comparable to that of Vit. C especially at 50 
 <italic>μ</italic>g/ml, 75 
 <italic>μ</italic>g/ml, and 100 
 <italic>μ</italic>g/ml of 
 <italic>IGESE</italic> (
 <xref rid="tab6" ref-type="table">Table 6</xref>).
</p>
